Advanced Cancer: JNJ-87704916 Tumor-Targeting Virus

We are testing a new virus that targets tumors in patients with advanced cancer. The goal is to see if it can effectively attack cancer cells when injected directly into the tumor.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Gustave Roussy
DITEP
Villejuif, France
Hospital Universitari Vall D Hebron
Medical Oncology
Barcelona, Spain
Hospital Universitario Hm Sanchinarro
Medical Oncology
Chamartín, Spain

Sponsor: Johnson And Johnson Enterprise Innovation Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.